Shineco, Inc., together with its subsidiaries, produces, distributes, and sells health and well-being focused plant-based products in China. It processes and distributes traditional Chinese herbal medicine products, as well as other pharmaceutical products directly to individual customers. The company also plants, processes, and distributes green and organic vegetables and fruits; and grows, cultivates, and sells yew trees that are used for the production of anti-cancer medication, as well as ornamental bonsai trees for purifying indoor air quality. In addition, it offers logistics services for agricultural products. Further, the company develops, manufactures, and distributes specialized fabrics, textiles, health supplements, and other byproducts derived from an indigenous Chinese plant Apocynum Venetum. The company sells its Chinese medicinal products and western medicines through wholesale customers; and its 13 Ankang retail pharmacies operating under the Sunsimiao Pharmacies name, as well as 66 pharmacies operated by third parties. It sells its decoction pieces on the Anhui Bozhou Chinese medicine transaction market to medical materials companies and Chinese patent medicine factories. The company sells its Luobuma textile products online through third party e-commerce websites, as well as through distributors under the Tenethealth brand; and yew trees and agricultural products primarily through its sales personnel, and group and institutional sales. The company was formerly known as Beijing Tenet Jove Technological Development Co., Ltd. and changed its name to Shineco, Inc. in June 2005. Shineco, Inc. was incorporated in 1997 and is based in Beijing, China.
IPO Year: 2016
Exchange: NASDAQ
Website: tianyiluobuma.com
BEIJING, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that effective at 12:01 a.m., EDT, on November 12, 2024, the Company will effect a one-for-twenty four (1-for-24) reverse stock split of its outstanding common stock (the "Reverse Stock Split"). The Reverse Stock Split is primarily intended to bring the Company into compliance with the minimum average closing share price requirement for maintaining its listing on the Nasdaq Capital Market. The Company's common stock will continue to trade under the symbol "SISI". Upon the effectiveness of the R
NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technology service provider, today announced that its Board of Directors (the "Board") approved the appointment of Mr. Hu Li as Chief Executive Officer ("CEO"), President and a member of the Board of the Company, effective August 5, 2024. Mr. Li will be fully responsible for the operation and management of the Company, helping it to expand internationally, manage its investment and financi
Beijing, July 15, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company") (NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the closing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-
Beijing, July 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company") (NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $1.07 per share of common stock, for aggregate gross proceeds of approximately $2 million, prior to deducting underwriting discounts and other offering expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 280,374 shares of common stock at the public offering price per share, less the underwriting discounts to cover over-
Beijing, July 11, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company") (NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, today announced it has commenced an underwritten public offering of shares of its common stock and pre-funded warrants to purchase its shares of common stock. All of the shares of common stock and pre-funded warrants and the shares of common stock underlying the pre-funded warrants are being offered by the Company. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. EF Hu
The Company believes that its Advanced Proprietary Production Technology Provides it with a Competitive Advantage in the Sector BEIJING, July 10, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that its subsidiary, Fuzhou Meida Health Management Co., Ltd. ("Fuzhou Meida"), has entered into Distribution Agreements (the "Agreements") for its water-soluble phospholipid concentrate health food beverage with a projected goal of more than $30 million in sales with six distribution companies, for a term of three years. Mrs. Jennifer Zhan, CEO of Shineco, said, "Th
BEIJING, June 27, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that on June 5, 2024, the Company received a formal notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). The notice indicated that as a result of the closing bid price of the Company's common stock having been at least $1.00 per share for the period of 10 consecutive business days, from May 20, 2024 through June 4, 2024, th
BEIJING, June 24, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on June 20, 2024, the Company entered into a Securities Purchase Agreement (the "SPA") with certain non-U.S. investors (each individually, a "Purchaser," and collectively, the "Purchasers"). Pursuant to the SPA, the Company will issue up to 1,400,000 shares of its common stock (the "Shares") to the Purchasers in a private placement financing transaction (the "Offering") at an offering price of $5.00 per share. The gross proceeds of the Offering are expected to be approximately $7,000,000,
BEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. ("Shineco" or the "Company"; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 18, 2024, it entered into an Investment Letter of Intent (the "Investment LOI") with Beijing Oriental Meitong Technology Co., Ltd. ("Meitong Technology") whereby Shineco intends to invest $20 million in Meitong Technology in exchange for 80% of Meitong Technology's shares. The Company believes that the acquisition of equity in Meitong Technology will add to the Company's core competencies and result in operating synergies that will enhance the Company's value proposition. Meitong Tec
Beijing, June 17, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 14, 2024, its 51% owned subsidiary, Shangkang Life Science and Technology (Jiangsu) Co., Ltd. ("Shangkang Life Science") entered into a Strategic Cooperation Framework Agreement ("the Agreement") with Turing Video (Shenzhen) Co., Ltd ("Turing Video") to jointly develop a series of smart medical products and introduce their biotechnology and other innovative health solutions to the healthcare market. Shangkang Life Science, a joint venture established by Shangkang Life Science and Ya
SC 13G/A - SHINECO, INC. (0001300734) (Subject)
SC 13D - SHINECO, INC. (0001300734) (Subject)
SC 13G - SHINECO, INC. (0001300734) (Subject)
SC 13D - SHINECO, INC. (0001300734) (Subject)
U.S. stocks traded higher toward the end of trading, with the Dow Jones index surging past the 40,000 mark on Friday. The Dow traded up 1.09% to 40,187.34 while the NASDAQ rose 1.30% to 18,521.69. The S&P 500 also rose, gaining, 1.12% to 5,647.26. Check This Out: This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Leading and Lagging SectorsInformation technology shares jumped by 1.5% on Friday. In trading on Friday, communication services shares fell by 0.2%. Top Headline Citigroup Inc (NYSE:C) reported better-than-expected results for its second quarter. The bank posted a second-quarter fiscal 2024 revenue growth of 4% year-ov
Shares of ASP Isotopes Inc. (NASDAQ:ASPI) fell during Friday's session after the company announced pricing of a $30 million public offering of 12 million shares at $2.50 per share. ASP Isotopes shares fell 9.2% to $3.2308 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Vicinity Motor Corp. (NASDAQ:VEV) shares jumped 133.2% to $0.7910 after the company announced CARB certification for the VMC 1200 class 3 electric truck. Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares rose 110% to $0.4335. TOYO Co., Ltd (NASDAQ:TOYO) climbed 63.4% to $2.5322. Nisun International Enterprise Development Group Co., Ltd (NASDAQ:NISN) jumped 58% to $9.52 foll
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Friday. The Dow traded up 0.85% to 40,090.44 while the NASDAQ rose 1.01% to 18,467.26. The S&P 500 also rose, gaining, 0.86% to 5,632.79. Check This Out: This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Leading and Lagging SectorsInformation technology shares jumped by 1.5% on Friday. In trading on Friday, communication services shares fell by 0.2%. Top Headline JPMorgan Chase & Co. (NYSE:JPM) reported better-than-expected second-quarter FY24 results. Reported revenue rose 22% Y/Y to $50.2 billion, beating the consensus of $42.3 b
Shineco Inc (NASDAQ:SISI) shares are trading lower by 53.6% to $0.98 during Friday’s session after the company announced pricing of a $2 million underwritten public offering. The company earlier said its public offering of 1,869,160 shares of common stock will be at $1.07 per share, totaling approximately $2 million before expenses. The company also granted underwriters a 45-day option to purchase an additional 280,374 shares to cover over-allotments. The offering is set to close on July 15, pending customary closing conditions. EF Hutton LLC is the sole book-running manager for the offering. Read Also: June Producer Inflation Exceeds Forecasts, Restrains Investor Euphoria Followin
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 100 points on Friday. Following the market opening Friday, the Dow traded up 0.25% to 39,853.88 while the NASDAQ rose 0.25% to 18,329.05. The S&P 500 also rose, gaining, 0.22% to 5,596.73. Check This Out: This Spotify Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Leading and Lagging SectorsReal estate shares jumped by 0.6% on Friday. In trading on Friday, communication services shares fell by 0.5%. Top Headline The Producer Price Index released Friday revealed a higher-than-expected increase in June. In June, the headline PPI for final demand rose by 0.2% mo
Shares of Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) rose sharply in today's pre-market trading after the company reported better-than-expected second-quarter sales and issued guidance. Ericsson reported a second-quarter loss of 31 cents per share, compared to year-ago earnings of 7 cents per share. The company reported quarterly sales of $5.59 billion which beat the analyst consensus estimate of $5.36 billion, according to data from Benzinga Pro. Ericsson shares jumped 4.3% to $6.66 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Sentage Holdings Inc. (NASDAQ:SNTG) rose 85.6% to $4.27 in pre-market trading after gaining around 5% on
On Wednesday, Shineco, Inc. (NASDAQ:SISI) announced that its subsidiary, Fuzhou Media, has signed three-year Distribution Agreements with six companies for its water-soluble phospholipid concentrate health food beverage, targeting over $30 million in sales. The stock is trading lower following the news report. Phospholipids are organic compounds crucial in food and other industries. They form cell membrane bilayers, regulating molecule passage and supporting cell growth and physiological processes due to their health benefits. The Company patented a physical extraction technology for phospholipids, using water solvent chromatography ultrafiltration to preserve natural structures and
NEW YORK, Aug. 9, 2024 /PRNewswire/ -- Future Fintech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technology service provider, today announced that its Board of Directors (the "Board") approved the appointment of Mr. Hu Li as Chief Executive Officer ("CEO"), President and a member of the Board of the Company, effective August 5, 2024. Mr. Li will be fully responsible for the operation and management of the Company, helping it to expand internationally, manage its investment and financi
BEIJING, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a provider of technologically advanced healthcare products and services, announced today that its Board of Directors has appointed Ms. Xiaohui Wang and Mr. Chi Keung Yan as executive officers of the Company in key leadership roles. Effective November 13, 2023, Shineco's Board of Directors appointed Ms. Xiaohui Wang as Executive President of the Company. From March 2000 to November 2013, Ms. Wang was the founder and Chairperson of Chongqing Wintus (New Star) Enterprises Group, where she was responsible for its corporate planning, supervision of the group's business in the Chongqing region,
BEIJING, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (("Shineco" or the "Company", NASDAQ:SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that the Company has appointed Professor Qiyin Sun as the Chief Medical Consultant. Professor Sun will lead the research and innovation of the Company's tumor treatment and provide technical consultation in early tumor screening and tumor radiotherapy to support the commercialization of digital tumor diagnosis and treatment. Prior to serving as the chief medical consultant at Shineco, Professor Sun was a director at Beijing Nuclear Medicine Equipment Engineering Technology R
3 - SHINECO, INC. (0001300734) (Issuer)
3 - SHINECO, INC. (0001300734) (Issuer)
3 - SHINECO, INC. (0001300734) (Issuer)
3 - SHINECO, INC. (0001300734) (Issuer)
4 - SHINECO, INC. (0001300734) (Issuer)
4 - SHINECO, INC. (0001300734) (Issuer)
3 - SHINECO, INC. (0001300734) (Issuer)
10-Q - SHINECO, INC. (0001300734) (Filer)
8-K - SHINECO, INC. (0001300734) (Filer)
8-K - SHINECO, INC. (0001300734) (Filer)
8-K - SHINECO, INC. (0001300734) (Filer)
DEF 14A - SHINECO, INC. (0001300734) (Filer)
10-K - SHINECO, INC. (0001300734) (Filer)
PRE 14A - SHINECO, INC. (0001300734) (Filer)
8-K - SHINECO, INC. (0001300734) (Filer)
8-K - SHINECO, INC. (0001300734) (Filer)
424B5 - SHINECO, INC. (0001300734) (Filer)